Study analyzes alterations in the cerebral cortex in people with psychosis
New research from the University of Seville suggests that the progression of psychosis, often associated with conditions like schizophrenia, isn’t uniform. Instead, its development is shaped by a complex interplay of brain development, the nature of symptoms experienced, cognitive abilities, and the course of treatment received.
Understanding Psychosis and its Complexity
Psychosis is characterized by symptoms such as hallucinations and delusions, representing a disconnect from reality. Researchers found that the presentation and evolution of these symptoms vary significantly between individuals, making schizophrenia a particularly challenging disorder to understand. The study highlights the need for treatment strategies tailored to each person’s unique experience.
Brain Changes During a First Psychotic Episode
The study examined 357 patients with schizophrenia and 195 control subjects using magnetic resonance imaging. Results showed that individuals experiencing a first psychotic episode often exhibit a reduction in cortical volume – the outer layer of the brain. This reduction was particularly noticeable in areas rich in serotonin and dopamine receptors, neurotransmitters crucial to both the development of psychosis and the effects of antipsychotic medications. The research also indicates a potential role for inflammatory and immunological processes within the brain.
Interestingly, these structural brain differences tended to lessen with treatment, suggesting that clinical intervention can slow the rate of brain deterioration. However, those requiring higher doses of antipsychotic medication over time continued to show more pronounced differences.
Cognitive Function and Treatment Response
The research confirmed that cognitive impairments are present from the earliest stages of psychosis, affecting areas like attention, memory, and processing speed. While many individuals experienced improvements in both symptoms and cognitive function with treatment, this improvement was less significant in those needing higher medication dosages.
Researchers at the Neuroimaging and Brain Networks Laboratory of the University of Seville, led by Claudio Alemán Morillo and Rafael Romero García, employed a novel percentile-based analysis. This method, similar to how growth is tracked in children, allows for the identification of atypical brain volumes in specific regions.
Frequently Asked Questions
What is the significance of studying cortical volume in psychosis?
The study suggests that reductions in cortical volume, particularly in areas with high concentrations of serotonin and dopamine receptors, are associated with the onset of psychosis. Understanding these structural changes may provide insights into the underlying mechanisms of the disorder.
Does this research indicate that antipsychotic medication is harmful?
The research does not suggest that antipsychotic medication causes brain volume loss. It indicates that patients with more severe symptoms, who often require higher doses, continue to exhibit more pronounced brain differences over time.
How might this research impact future treatment approaches?
The findings emphasize the need for personalized approaches to treatment, taking into account individual differences in brain development, symptoms, cognition, and response to medication. This could lead to more effective, targeted therapies.
How might a more personalized approach to understanding and treating psychosis improve the lives of those affected?